Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Lisata Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 34 | +10 |
| Shares | 715.1K | 270.9K | 1.41M | +965.8K (+217.5%) |
| Value | $1.36M | $503.9K | $7.06M | +$6.21M (+728.4%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Lisata Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deeter Investments LLP | 364,479 | $1.83M | 0.32% |
| Vanguard Capital Management LLC | 271,815 | $1.36M | 0.00% |
| Deltec Asset Management LLC | 90,000 | $450.9K | 0.08% |
| Rangeley Capital, LLC | 75,000 | $375.8K | 0.41% |
| CSS LLC | 61,898 | $310.1K | 0.02% |
| PenderFund Capital Management Ltd. | 47,500 | $238.0K | 0.04% |
| Virtu Financial LLC | 42,213 | $211.0K | 0.01% |
| Vanguard Fiduciary Trust Co | 34,917 | $174.9K | 0.00% |
| GTS Securities LLC | 31,396 | $157.3K | 0.01% |
| Citadel Advisors LLC | 22,666 | $113.6K | 0.00% |
| JBF Capital, Inc. | 13,234 | $66.3K | 0.01% |
| Susquehanna International Group, LLP | 11,604 | $58.1K | 0.00% |
| Vanguard Global Advisers, LLC | 1,033 | $5.17K | 0.00% |
| Caitong International Asset Management Co., Ltd | 22 | $110 | 0.00% |
Sold out (4)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| BML Capital Management, LLC | 73,348 | $136.4K |
| Ground Swell Capital, LLC | 38,987 | $72.5K |
| Dimensional Fund Advisors LP | 14,253 | $26.5K |
| GWM Advisors LLC | 107 | $199 |
Not filed for Q1 2026 yet (1)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 270,909 | $503.9K |